中宠股份(002891) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 reached ¥1,232,273,861.54, representing a 23.55% increase year-over-year[1]. - Net profit attributable to shareholders was ¥139,523,995.81, a significant increase of 73.18% compared to the same period last year[1]. - The net profit after deducting non-recurring gains and losses was ¥104,511,457.85, up 34.27% year-over-year[1]. - Total operating revenue for Q3 2024 reached ¥3,188,643,213.93, an increase of 17.6% compared to ¥2,712,334,231.77 in the same period last year[13]. - Net profit attributable to shareholders of the parent company was ¥281,959,622.61, up from ¥176,735,549.56 in the previous year, representing a growth of 59.5%[15]. - The company's operating profit for the quarter was ¥378,348,825.15, up from ¥288,448,903.34, reflecting a growth of 31.2%[14]. - The company reported a net profit of ¥76,192,892.54 for the quarter, compared to ¥63,503,184.93 in the previous year, an increase of 19.5%[14]. - Basic earnings per share for Q3 2024 were ¥0.9618, compared to ¥0.6039 in the same period last year, an increase of 59.2%[15]. Assets and Liabilities - The total assets at the end of the reporting period were ¥4,322,691,042.35, showing a decrease of 1.54% from the end of the previous year[1]. - The company's total liabilities decreased to ¥1,684,862,901.50 from ¥1,970,843,441.21, a reduction of 14.5%[12]. - The total assets of the company decreased from CNY 4.39 billion to CNY 4.32 billion, a decline of about 1.6%[11]. - The company's short-term borrowings decreased from CNY 665.50 million to CNY 387.85 million, a reduction of approximately 41.7%[11]. - The total non-current assets increased from CNY 2.37 billion to CNY 2.38 billion, a growth of approximately 0.5%[11]. - The total equity attributable to shareholders increased by 10.00% to ¥2,456,137,700.10 compared to the end of the previous year[1]. - The total equity attributable to shareholders of the parent company increased to ¥2,456,137,700.10, up from ¥2,232,803,268.30, marking an increase of 10.0%[12]. Cash Flow - The company reported a net cash flow from operating activities of ¥198,248,965.85, which decreased by 31.42% year-over-year[1]. - The net cash flow from operating activities for the current period is ¥198,248,965.85, a decrease of 31.5% compared to ¥289,074,950.80 in the previous period[17]. - Total cash inflow from operating activities is ¥3,132,794,881.00, up 12.5% from ¥2,784,022,140.16 in the previous period[17]. - Cash outflow from financing activities increased significantly to ¥1,025,865,569.44, compared to ¥415,958,476.24 in the previous period, resulting in a net cash flow from financing activities of -¥323,496,989.44[18]. - The cash and cash equivalents at the end of the period decreased to ¥369,280,799.58 from ¥286,317,564.03 in the previous period[18]. - Cash inflow from investment activities is ¥610,636,455.17, down 41.1% from ¥1,038,426,052.78 in the previous period[17]. - The company’s total cash inflow from investment activities was significantly impacted, resulting in a net cash flow from investment activities of ¥63,603,429.96, compared to -¥670,272,456.38 in the previous period[17]. Expenses - Research and development expenses rose by 40.29% to ¥5,095.65 million, indicating increased investment in innovation[5]. - Sales expenses increased by 32.42% to ¥33,318.40 million, reflecting higher marketing expenditures[5]. - The company paid ¥871,254,984.04 in debt repayment, significantly higher than ¥232,903,038.63 in the previous period[18]. - The cash outflow for purchasing fixed assets and intangible assets was ¥215,283,025.21, down from ¥347,522,009.16 in the previous period[17]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 25,749, with the largest shareholder, Yantai Zhongxing Biotechnology Co., Ltd., holding 24.86%[8]. - The top ten shareholders collectively hold a significant portion of the company's shares, with the top three alone accounting for 52.16%[8]. - The company has engaged in share repurchase activities, with a total of 4,463,858 shares held in a repurchase account, representing 1.52% of total shares[9]. Government Support - The company received government subsidies amounting to ¥10,098,911.70 year-to-date, contributing positively to its financial performance[2]. Accounts Receivable and Inventory - Accounts receivable increased significantly from CNY 467.59 million to CNY 731.38 million, indicating a rise of approximately 56.3%[11]. - Inventory decreased slightly from CNY 580.46 million to CNY 553.25 million, a decline of about 4.7%[11].